Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing
- PMID: 37943047
- PMCID: PMC10715159
- DOI: 10.1128/spectrum.02716-23
Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing
Abstract
Accurate and fast molecular testing is important for the diagnosis and control of COVID-19. During patient surges in the COVID-19 pandemic, laboratories were challenged by a higher demand for molecular testing under skilled staff shortages. We developed an automated multipurpose molecular testing system, named PCRpack, for the rapid, high-throughput testing of infectious pathogens, including SARS-CoV-2. The system is provided in an all-in-one package, including a liquid handling instrument, a laboratory information management system, and other materials needed for testing operation; is highly customizable; and is easily implemented. PCRpack showed robust liquid handling performance, high clinical diagnostic performance, a shorter turn-around time with minimal hands-on time, and a high testing capacity. These features contribute to the rapid implementation of the high-performance and high-throughput molecular testing environment at any phase of the pandemic caused by SARS-CoV-2 or future emerging pathogens.
Keywords: COVID-19; RT-PCR; SARS-CoV-2; automation; liquid handling instrument.
Conflict of interest statement
Y.M. received research funds from Beckman Coulter, Nippon Control System, Toyobo, and Precision System Science. M.N. received research funds from Beckman Coulter and Precision System Science. T.N. is an employee of Beckman Coulter, and K.K. is an employee of Nippon Control System. The funding organizations had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.
Figures
References
-
- Nolte FS, Babady NE, Buchan BW, Capraro GA, Graf EH, Leber AL, McElvania E, Yao JDC. 2020. Responding to the challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): perspectives from the association for molecular pathology infectious disease subdivision leadership. J Mol Diagn 22:968–974. doi: 10.1016/j.jmoldx.2020.06.003 - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
